Comparison of the effect of a combination of eight micronutrients versus a standard mono preparation on sperm parameters

Reproductive Biology and Endocrinology

Volumn 14, Issue 1, 2016, Pages

  Lipovac, Markus ^a,b   Bodner, Florian ^a,b   Imhof, Martin ^a,b,c   Chedraui, Peter ^d  

^a Fertility Clinic IMI   (Austria)

^b Karl Landsteiner Institute for Cell based Therapy in Gynecology   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d UNIVERSIDAD CATÓLICA DE SANTIAGO DE GUAYAQUIL   (Ecuador)

Author keywords

Combined treatment; L carnitine; Micronutrients; Mono treatment; Sperm parameters

Indexed keywords

ALPHA TOCOPHEROL; ARGININE; CARNITINE; CLOMIFENE CITRATE; FOLIC ACID; GLUTATHIONE; SELENIUM; TRACE ELEMENT; UBIDECARENONE; ZINC; DRUG COMBINATION; UBIQUINONE;

ADULT; AGE; ARTICLE; BODY MASS; COMBINATION CHEMOTHERAPY; COMPARATIVE EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MALE GENITAL TRACT PARAMETERS; MALE SUBFERTILITY; MONOTHERAPY; PROSPECTIVE STUDY; SEMEN ANALYSIS; SPERM; SPERMATOZOON DENSITY; SPERMATOZOON MORPHOLOGY; SPERMATOZOON MOTILITY; SPERMATOZOON VOLUME; SUBFERTILITY; TREATMENT DURATION; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; DRUG COMBINATION; DRUG EFFECTS; INFERTILITY, MALE; MIDDLE AGED; SPERMATOZOON; SPERMATOZOON COUNT;

ADULT; ARGININE; CARNITINE; DRUG COMBINATIONS; FOLIC ACID; GLUTATHIONE; HUMANS; INFERTILITY, MALE; MALE; MICRONUTRIENTS; MIDDLE AGED; SELENIUM; SEMEN ANALYSIS; SPERM COUNT; SPERM MOTILITY; SPERMATOZOA; UBIQUINONE; VITAMIN E; ZINC;

EID: 85003587489     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/s12958-016-0219-0     Document Type: Article

References (71)

1. Breckwoldt M, Kaufmann M, Pfleiderer A. (Hg.). Gynäkologie und Geburtshilfe. Stuttgart: Georg Thieme Verlag; 2008.
2. Cavallini G. Male idiopathic oligoasthenoteratozoospermia. Asian J Androl. 2006;8:143-57.
3. Hancke K, Denschlag D, Gitsch G, Keck C. Therapeutische Ansätze bei idiopathischer Infertilität des Mannes. Geburtshilfe Frauenheilkd. 2006;66:26-33.
4. Carlsen E, Giwercman A, Keiding N, Skakkebaek NE. Evidence for decreasing quality of semen during past 50 years. BMJ. 1992;305:609-13.
5. Osser S, Liedholm P, Ranstam J. Depressed semen quality: a study over two decades. Arch Androl. 1984;12:113-6.
6. Agarwal A, Prabakaran SA. Mechanism, measurement, and prevention of oxidative stress in male reproductive physiology. Indian J Exp Biol. 2005;43:963-74.
7. De Celis R, Pedrón-Nuevo N, Feria-Velasco A. Toxicology of male reproduction in animals and humans. Arch Androl. 1996;37:201-18.
8. Glander HJ, Paasch U, Grunewald S. Medikamtöse Therapieansätze zur Behandlung der männlichen Infertilität. Blickpunkt der Mann. 2007;5:19-24.
9. Safarinejad MR. Efficacy of coenzyme Q10 on semen parameters, sperm function and reproductive hormones in infertile men. J Urol. 2009;182:237-48.
10. Balázs C, Rácz K. The role of selenium in endocrine system diseases. Orv Hetil. 2013;154:1628-35.
11. Garratt M, Bathgate R, de Graaf SP, Brooks RC. Copper-zinc superoxide dismutase deficiency impairs sperm motility and in vivo fertility. Reproduction. 2013;146:297-304.
12. Ochsendorf FR, Buhl R, Bästlein A, Beschmann H. Glutathione in spermatozoa and seminal plasma of infertile men. Hum Reprod. 1998;13:353-9.
13. Fertilitätsstörung: Spoiler am Sperma, Doccheck news, 7th Feb. 2014. http://news.doccheck.com/de/37578/fertilitaetsstoerung-spoiler-am-sperma.
14. Agarwal A, Saleh RA, Bedaiwy MA. Role of reactive oxygen species in the pathophysiology of human reproduction. Fertil Steril. 2003;79:829-43.
15. Khosrowbeygi A, Zarghami N. Levels of oxidative stress biomarkers in seminal plasma and their relationship with seminal parameters. BMC Clin Pathol. 2007;7:6.
16. Sawyer DE, Mercer BG, Wiklendt AM, Aitken RJ. Quantitative analysis of gene-specific DNA damage in human spermatozoa. Mutat Res. 2003;529:21-34.
17. Showell MG, Brown J, Yazdani A, Stankiewicz MT, Hart RJ. Antioxidants for male subfertility. Cochrane Database Syst Rev. 2011;1, CD007411.
18. Aitken RJ, Clarkson JS, Fishel S. Generation of reactive oxygen species, lipid peroxidation, and human sperm function. Biol Reprod. 1989;41:183-97.
19. Agarwal A, Allamaneni SS, Said TM. Chemiluminescence technique for measuring reactive oxygen species. Reprod Biomed Online. 2004;9:466-8.
20. Aitken RJ, Harkiss D, Buckingham DW. Analysis of lipid peroxidation mechanisms in human spermatozoa. Mol Reprod Dev. 1993;35:302-15.
21. Suleiman SA, Ali ME, Zaki ZM, el-Malik EM, Nasr MA. Lipid peroxidation and human sperm motility: protective role of vitamin E. J Androl. 1996;17:530-7.
22. Sukcharoen N, Keith J, Irvine DS, Aitken RJ. Predicting the fertilizing potential of human sperm suspensions in vitro: importance of sperm morphology and leukocyte contamination. Fertil Steril. 1995;63:1293-300.
23. Hansen M, Kurinczuk JJ, Bower C, Webb S. The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization. N Engl J Med. 2002;346:725-30.
24. Carrell DT, Liu L, Peterson CM, Jones KP, Hatasaka HH, Erickson L, et al. Sperm DNA fragmentation is increased in couples with unexplained recurrent pregnancy loss. Arch Androl. 2003;49:49-55.
25. Baker MA, Aitken RJ. Reactive oxygen species in spermatozoa: methods for monitoring and significance for the origins of genetic disease and infertility. Reprod Biol Endocrinol. 2005;3:67.
26. Lewis SE, Aitken RJ. DNA damage to spermatozoa has impacts on fertilization and pregnancy. Cell Tissue Res. 2005;322:33-41.
27. Ji BT, Shu XO, Linet MS, Zheng W, Wacholder S, Gao YT, et al. Paternal cigarette smoking and the risk of childhood cancer among offspring of nonsmoking mothers. J Natl Cancer Inst. 1997;89:238-44.
28. Crow JF. The origins, patterns and implications of human spontaneous mutation. Nat Rev Genet. 2000;1:40-7.
29. Sipos A, Rasmussen F, Harrison G, Tynelius P, Lewis G, Leon DA, Gunnell D. Paternal age and schizophrenia: a population based cohort study. BMJ. 2004;329:1070.
30. Vestergaard M, Mork A, Madsen KM, Olsen J. Paternal age and epilepsy in the off-spring. Eur J Epidemiol. 2005;20:1003-5.
31. Reichenberg A, Gross R, Weiser M, Bresnahan M, Silverman J, Harlap S, et al. Advancing paternal age and autism. Arch Gen Psychiatry. 2006;63:1026-32.
32. Aitken RJ, De Iuliis GN, McLachlan RI. Biological and clinical significance of DNA damage in the male germ line. Int J Androl. 2009;32:46-56.
33. Gharagozloo P, Aitken RJ. The role of sperm oxidative stress in male infertility and the significance of oral antioxidant therapy. Hum Reprod. 2011;26:1628-40.
34. Lenzi A, Lombardo F, Sgrò P, Salacone P, Caponecchia L, Dondero F, et al. Use of carnitine therapy in selected cases of male factor infertility: a double-blind crossover trial. Fertil Steril. 2003;79:292-300.
35. Zhou X, Liu F, Zhai S. Effect of L-carnitine and/or L-acetyl-carnitine in nutrition treatment for male infertility: a systematic review. Asia Pac J Clin Nutr. 2007;16:383-90.
36. Matalliotakis I, Koumantaki Y, Evageliou A, Matalliotakis G, Goumenou A, Koumantakis E. L-carnitine levels in the seminal plasma of fertile and infertile men: correlation with sperm quality. Int J Fertil Womens Med. 2000;45:236-40.
37. Balercia G, Mosca F, Mantero F, Boscaro M, Mancini A, Ricciardo-Lamonica G, et al. Coenzyme Q(10) supplementation in infertile men with idiopathic asthenozoospermia: an open, uncontrolled pilot study. Fertil Steril. 2004;81:93-8.
38. Lenzi A, Culasso F, Gandini L, Lombardo F, Dondero F. Placebo-controlled, double-blind, cross-over trial of glutathione therapy in male infertility. Hum Reprod. 1993;8:1657-62.
39. Netter A, Hartoma R, Nahoul K. Effect of zinc administration on plasma testosterone, dihydrotestosterone and sperm count. Arch Androl. 1981;7:69-73.
40. Imhof M, Matthai C, Huber JC. Einsatz von Profertil® zur Therapie des "Male factors" und Verbesserung des Spermiogramms. Gyn-Aktiv. 2007;2:68.
41. Stanislavov R, Rohdewald P. Sperm quality in men is improved by supplementation with a combination of L-arginine, L-citrullin, roburins and Pycnogenol®. Minerva Urol Nefrol. 2014;66:217-23.
42. Wong WY, Merkus HM, Thomas CM, Menkveld R, Zielhuis GA, Steegers-Theunissen RP. Effects of folic acid and zinc sulfate on male factor subfertility: a double-blind, randomized, placebo-controlled trial. Fertil Steril. 2002;77:491-8.
43. Balercia G, Regoli F, Armeni T, Koverech A, Mantero F, Boscaro M. Placebo-controlled double-blind randomized trial on the use of L-carnitine, L-acetylcarnitine, or combined L-carnitine and L-acetylcarnitine in men with idiopathic asthenozoospermia. Fertil Steril. 2005;84:662-71.
44. Ahmed MM, Ibrahim ZS, Alkafafy M, El-Shazly SA. L-carnitine protects against testicular dysfunction caused by gamma irradiation in mice. Acta Histochem. 2014;116:1046-55.
45. Topcu-Tarladacalisir Y, Kanter M, Uzal MC. Role of L-carnitine in the prevention of seminiferous tubules damage induced by gamma radiation: a light and electron microscopic study. Arch Toxicol. 2009;83:735-46.
46. Lenzi A, Sgrò P, Salacone P, Paoli D, Gilio B, Lombardo F, et al. A placebo-controlled double-blind randomized trial of the use of combined l-carnitine and l-acetyl-carnitine treatment in men with asthenozoospermia. Fertil Steril. 2004;81:1578-84.
47. Ahmed SD, Karira KA, Jagdesh, Ahsan S. Role of L-carnitine in male infertility. J Pak Med Assoc. 2011;61:732-6.
48. Hellstrom WJ, Bell M, Wang R, Sikka SC. Effect of sodium nitroprusside on sperm motility, viability, and lipid peroxidation. Fertil Steril. 1994;61:1117-22.
49. Zhang H, Zheng RL. Possible role of nitric oxide on fertile and asthenozoospermic infertile human sperm functions. Free Radic Res. 1996;25:347-54.
50. James AM, Smith RA, Murphy MP. Antioxidant and prooxidant properties of mitochondrial Coenzyme Q. Arch Biochem Biophys. 2004;423:47-56.
51. Safarinejad MR, Safarinejad S, Shafiei N, Safarinejad S. Effects of the reduced form of coenzyme Q10 (ubiquinol) on semen parameters in men with idiopathic infertility: a double-blind, placebo controlled, randomized study. J Urol. 2012;188:526-31.
52. Garcia PC, Piffer RC, Gerardin DC, Sankako MK, Alves de Lima RO, Pereira OC. Could zinc prevent reproductive alterations caused by cigarette smoke in male rats? Reprod Fertil Dev. 2012;24:559-67.
53. Babaei H, Abshenas J. Zinc therapy improves adverse effects of long term administration of copper on epididymal sperm quality of rats. Iran J Reprod Med. 2013;11:577-82.
54. Omu AE, Dashti H, Al-Othman S. Treatment of asthenozoospermia with zinc sulphate: andrological, immunological and obstetric outcome. Eur J Obstet Gynecol Reprod Biol. 1998;79:179-84.
55. Hartoma TR, Nahoul K, Netter A. Zinc, plasma androgens and male sterility. Lancet. 1977;2:1125-6.
56. Tikkiwal M, Ajmera RL, Mathur NK. Effect of zinc administration on seminal zinc and fertility of oligospermic males. Indian J Physiol Pharmacol. 1987;31:30-4.
57. Lishko PV, Kirichok Y. The role of Hv1 and CatSper channels in sperm activation. J Physiol. 2010;588:4667-72.
58. Bentivoglio G, Melica F, Cristoforoni P. Folinic acid in the treatment of human male infertility. Fertil Steril. 1993;60:698-701.
59. Aitken RJ, De Iuliis GN. On the possible origins of DNA damage in human spermatozoa. Mol Hum Reprod. 2010;16:3-13.
60. Tunc O, Thompson J, Tremellen K. Improvement in sperm DNA quality using an oral antioxidant therapy. Reprod Biomed Online. 2009;18:761-8.
61. Landau B, Singer R, Klein T, Segenreich E. Folic acid levels in blood and seminal plasma of normo- and oligospermic patients prior and following folic acid treatment. Experientia. 1978;34:1301-2.
62. Ibrahim W, Tousson E, El-Masry T, Arafa N, Akela M. The effect of folic acid as an antioxidant on the hypothalamic monoamines in experimentally induced hypothyroid rat. Toxicol Ind Health. 2012;28:253-61.
63. Tousson E, Ali EM, Ibrahim W, Mansour MA. Treatment with folic acid ameliorated the histopathological alterations caused by propylthiouracil-induced hypothyroid rat testes. Toxicol Ind Health. 2012;28:566-76.
64. Keskes-Ammar L, Feki-Chakroun N, Rebai T, Sahnoun Z, Ghozzi H, Hammami S, et al. Sperm oxidative stress and the effect of an oral vitamin E and selenium supplement on semen quality in infertile men. Arch Androl. 2003;49:83-94.
65. Ahsan U, Kamran Z, Raza I, Ahmad S, Babar W, Riaz MH, et al. Role of selenium in male reproduction - a review. Anim Reprod Sci. 2014;146:55-62.
66. Beckett GJ, Arthur JR. Selenium and endocrine systems. J Endocrinol. 2005;184:455-65.
67. Vézina D, Mauffette F, Roberts KD, Bleau G. Selenium-vitamin E supplementation in infertile men. Effects on semen parameters and micronutrient levels and distribution. Biol Trace Elem Res. 1996;53:65-83.
68. Kodama H, Yamaguchi R, Fukuda J, Kasai H, Tanaka T. Increased oxidative deoxyribonucleic acid damage in the spermatozoa of infertile male patients. Fertil Steril. 1997;68:519-24.
69. Garolla A, Maiorino M, Roverato A, Roveri A, Ursini F, Foresta C. Oral carnitine supplementation increases sperm motility in asthenozoospermic men with normal sperm phospholipid hydroperoxide glutathione peroxidase levels. Fertil Steril. 2005;83:355-61.
70. Horn F, Moc I, Schneider N, Grillhösl C, Berghold S, Lindenmeier G. (Hg.). Biochemie des Menschen. 2005. p. 3.
71. Wang YX, Yang SW, Qu CB, Huo HX, Li W, Li JD, et al. L-carnitine: safe and effective for asthenozoospermia. Zhonghua Nan Ke Xue. 2010;16:420-2.